• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 60 天预后明确的老年 COVID-19 患者小样本的临床特征和生存分析。

Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome.

机构信息

Geriatric Unit, Department of Palliative Medicine, Poznan University of Medical Sciences, 61-245 Poznan, Poland.

Department of Biology and Environmental Protection, Poznan University of Medical Sciences, 60-806 Poznan, Poland.

出版信息

Int J Environ Res Public Health. 2020 Nov 12;17(22):8362. doi: 10.3390/ijerph17228362.

DOI:10.3390/ijerph17228362
PMID:33198124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7698090/
Abstract

The older population is one of the most vulnerable to experience adverse outcomes of COVID-19. Exploring different clinical features that may act as detrimental to this population's survival is pivotal for recognizing the highest risk individuals for poor outcome. We thus aimed to characterize the clinical differences between 60-day survivors and non-survivors, as well as analyze variables influencing survival in the first older adults hospitalized in Poznan, Poland, with COVID-19. Symptoms, comorbidities, complications, laboratory results, and functional capacity regarding the first 50 older patients (≥60 years) hospitalized due to COVID-19 were retrospectively studied. Functional status before admission (dependent/independent) was determined based on medical history. The 60-day survivors ( = 30/50) and non-survivors ( = 20/50) were compared across clinical parameters. The patients had a mean age of 74.8 ± 9.4 years. Overall, 20/50 patients died during hospitalization, with no further fatal outcomes reported during the 60-day period. The non-survivors were on average older (78.3 ± 9.7 years), more commonly experienced concurrent heart disease (75%), and displayed functional dependence (65%) ( < 0.05). When assessing the variables influencing survival (age, heart disease, and functional dependence), using a multivariate proportional hazards regression, functional dependence (requiring assistance in core activities of daily living) was the main factor affecting 60-day survival (HR, 3.34; 95% CI: 1.29-8.63; = 0.01). In our study, functional dependence was the most important prognostic factor associated with mortality. Elderly with COVID-19 who required assistance in core activities of daily living prior to hospitalization had a three times increased risk to experience mortality, as compared to those with complete independence. Exploring geriatric approaches, such as assessment of functional capacity, may assist in constructing comprehensive survival prognosis in the elderly COVID-19 population.

摘要

老年人群体是感染 COVID-19 后最容易出现不良后果的人群之一。探索可能对这一人群的生存造成不利影响的不同临床特征,对于识别预后不良的高危个体至关重要。因此,我们旨在描述波兰波兹南首次因 COVID-19 住院的老年患者(≥60 岁)中 60 天幸存者与非幸存者之间的临床差异,并分析影响其生存的变量。回顾性研究了 50 名因 COVID-19 首次住院的老年患者(≥60 岁)的症状、合并症、并发症、实验室结果和功能能力。入院前的功能状态(依赖/独立)根据病史确定。将 60 天幸存者(n=30/50)和非幸存者(n=20/50)的临床参数进行比较。患者的平均年龄为 74.8±9.4 岁。总体而言,50 名患者中有 20 名在住院期间死亡,在 60 天期间没有进一步的死亡。非幸存者的年龄平均较大(78.3±9.7 岁),更常见合并心脏病(75%),并表现出功能依赖(65%)(<0.05)。当评估影响生存的变量(年龄、心脏病和功能依赖)时,使用多变量比例风险回归,功能依赖(日常生活活动的核心活动需要帮助)是影响 60 天生存的主要因素(HR,3.34;95%CI:1.29-8.63;=0.01)。在我们的研究中,功能依赖是与死亡率相关的最重要的预后因素。与完全独立的患者相比,住院前日常生活活动核心活动需要帮助的 COVID-19 老年患者死亡风险增加了三倍。探索老年方法,如功能能力评估,可能有助于构建老年 COVID-19 人群的综合生存预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc9f/7698090/533bbd5d3dda/ijerph-17-08362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc9f/7698090/533bbd5d3dda/ijerph-17-08362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc9f/7698090/533bbd5d3dda/ijerph-17-08362-g001.jpg

相似文献

1
Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome.对 60 天预后明确的老年 COVID-19 患者小样本的临床特征和生存分析。
Int J Environ Res Public Health. 2020 Nov 12;17(22):8362. doi: 10.3390/ijerph17228362.
2
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
3
Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge Study.COVID-19 老年患者住院死亡率的预测因素:COVIDAge 研究。
J Am Med Dir Assoc. 2020 Nov;21(11):1546-1554.e3. doi: 10.1016/j.jamda.2020.09.014. Epub 2020 Sep 15.
4
Potential Predictors of Poor Prognosis among Critical COVID-19 Pneumonia Patients Requiring Tracheal Intubation.危重型 COVID-19 肺炎需行气管插管患者预后不良的潜在预测因素。
Tohoku J Exp Med. 2020 Oct;252(2):103-107. doi: 10.1620/tjem.252.103.
5
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.纽约市中心医院新冠肺炎的经历与当前数据:美国新冠疫情中心的回顾性分析
J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548.
6
Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.新型冠状病毒肺炎所致危重症:南达科他州苏福尔斯市某单一中心的激增情况描述
S D Med. 2020 Jul;73(7):312-317.
7
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.空腹血糖受损和糖尿病与 2019 冠状病毒病患者的并发症和死亡率升高相关。
Front Endocrinol (Lausanne). 2020 Jul 10;11:525. doi: 10.3389/fendo.2020.00525. eCollection 2020.
8
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.感染 SARS-CoV-2 的非甾体抗炎药使用者的不良结局和死亡率:一项丹麦全国队列研究。
PLoS Med. 2020 Sep 8;17(9):e1003308. doi: 10.1371/journal.pmed.1003308. eCollection 2020 Sep.
9
Predictors of fatality including radiographic findings in adults with COVID-19.COVID-19 成人患者病死率的预测因素包括影像学表现。
Respir Res. 2020 Jun 11;21(1):146. doi: 10.1186/s12931-020-01411-2.
10
Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea.韩国 COVID-19 住院老年患者的死亡和呼吸支持危险因素。
J Korean Med Sci. 2020 Jun 15;35(23):e223. doi: 10.3346/jkms.2020.35.e223.

引用本文的文献

1
COVID-19 susceptibility, severity, and vaccine effectiveness in patients with psoriasis: a nationwide cohort study in South Korea.银屑病患者的新型冠状病毒肺炎易感性、严重程度及疫苗有效性:韩国一项全国性队列研究
Sci Rep. 2025 Jul 15;15(1):25608. doi: 10.1038/s41598-025-06495-8.
2
Dependence in Activities of Daily Living as a Predictor of In-Hospital Mortality During COVID-19 in Older Individuals.日常生活活动能力依赖作为老年人 COVID-19 住院期间死亡率的预测指标
Life (Basel). 2025 Feb 11;15(2):271. doi: 10.3390/life15020271.
3
Atypical Presentation of COVID-19 in Older Adults: A Scoping Review.

本文引用的文献

1
Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters.大流行中心非老年人群和非老年无基础疾病人群的 COVID-19 总体人群死亡率风险。
Environ Res. 2020 Sep;188:109890. doi: 10.1016/j.envres.2020.109890. Epub 2020 Jul 1.
2
COVID 19 - Clinical Picture in the Elderly Population: A Qualitative Systematic Review.2019冠状病毒病——老年人群的临床表现:一项定性系统评价
Aging Dis. 2020 Jul 23;11(4):988-1008. doi: 10.14336/AD.2020.0620. eCollection 2020 Jul.
3
Correlations between COVID-19 and burden of dementia: An ecological study and review of literature.
老年人中新冠肺炎的非典型表现:一项范围综述
Port J Public Health. 2023 Oct 27;41(3):198-217. doi: 10.1159/000534250. eCollection 2023 Dec.
4
COVID-19 in Elderly Patients: Risk Factors for Disease Severity.老年患者中的新冠肺炎:疾病严重程度的危险因素
Infect Dis Clin Microbiol. 2022 Mar 10;4(1):7-17. doi: 10.36519/idcm.2022.93. eCollection 2022 Mar.
5
Older patients with COVID-19 and neuropsychiatric conditions: A study of risk factors for mortality.老年 COVID-19 患者伴神经精神疾病:一项死亡率危险因素研究。
Brain Behav. 2022 Dec;12(12):e2787. doi: 10.1002/brb3.2787. Epub 2022 Nov 10.
6
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe.因严重急性呼吸综合征冠状病毒 2 型导致的死亡率、重症监护病房和医院收治的预后因素:欧洲队列研究的系统评价和荟萃分析。
Eur Respir Rev. 2022 Nov 2;31(166). doi: 10.1183/16000617.0098-2022. Print 2022 Dec 31.
7
Cost-effectiveness analysis of COVID-19 vaccination in Poland.波兰新冠疫苗接种的成本效益分析。
Arch Med Sci. 2021 Dec 18;18(4):1021-1030. doi: 10.5114/aoms/144626. eCollection 2022.
8
Animal models for COVID-19: advances, gaps and perspectives.用于 COVID-19 的动物模型:进展、差距与展望。
Signal Transduct Target Ther. 2022 Jul 7;7(1):220. doi: 10.1038/s41392-022-01087-8.
9
Quality of the Healthcare Services During COVID-19 Pandemic in Selected European Countries.在选定的欧洲国家,COVID-19 大流行期间的医疗服务质量。
Front Public Health. 2022 May 12;10:870314. doi: 10.3389/fpubh.2022.870314. eCollection 2022.
10
Patient Perceptions on Receiving Vaccination Services through Community Pharmacies.患者对通过社区药店接受疫苗接种服务的看法。
Int J Environ Res Public Health. 2022 Feb 22;19(5):2538. doi: 10.3390/ijerph19052538.
新冠病毒与痴呆负担的相关性:一项生态学研究和文献综述。
J Neurol Sci. 2020 Sep 15;416:117013. doi: 10.1016/j.jns.2020.117013. Epub 2020 Jul 4.
4
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study.衰弱对 COVID-19 患者生存的影响(COPE):一项多中心、欧洲、观察性队列研究。
Lancet Public Health. 2020 Aug;5(8):e444-e451. doi: 10.1016/S2468-2667(20)30146-8. Epub 2020 Jun 30.
5
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.COVID-19 不同于 SARS-CoV-2 阴性社区获得性肺炎。
Front Cell Infect Microbiol. 2020 Jun 16;10:322. doi: 10.3389/fcimb.2020.00322. eCollection 2020.
6
Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies.代谢综合征与2019冠状病毒病:相关合并症及拟用治疗方法的最新进展
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):809-814. doi: 10.1016/j.dsx.2020.06.016. Epub 2020 Jun 11.
7
Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?高血压是否是 COVID-19 大流行中预后不良的真正危险因素?
Curr Hypertens Rep. 2020 Jun 13;22(6):43. doi: 10.1007/s11906-020-01057-x.
8
A complication of coronavirus disease 2019: delirium.新型冠状病毒肺炎的并发症:意识障碍。
Acta Neurol Belg. 2020 Aug;120(4):927-932. doi: 10.1007/s13760-020-01401-7. Epub 2020 Jun 10.
9
COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review.新型冠状病毒肺炎:超越炎症的血红蛋白、铁与缺氧。一篇综述。
Clin Pract. 2020 May 28;10(2):1271. doi: 10.4081/cp.2020.1271. eCollection 2020 May 19.
10
Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.瑞典严重 COVID-19 的预后因素负担和流行情况。
Eur J Epidemiol. 2020 May;35(5):401-409. doi: 10.1007/s10654-020-00646-z. Epub 2020 May 18.